Dr. Hu earned his Ph.D in Biostatistics from the University of Washington, School of Public Health in 2010. He was an assistant professor in the Division of Epidemiology at the University of Utah, School of Medicine, and an investigator and biostatistician at Huntsman Cancer Institute (HCI) from 2013 to 2019. Dr. Hu has a broad biostatistics/epidemiology background, with specific training and expertise in the areas of survival analysis, longitudinal analysis, meta-data analysis and analysis of missing data. As the investigator in the Cancer Control and Population Sciences (CCPS) at HCI, I was involved in several clinical trials and cohort studies in breast cancer, myeloma, skin cancer, endometrial cancer and brain cancer. He also developed novel methods in cancer diagnosis and efficacy trials. At HCI, I successfully managed and completed two internal grants as the study PI and study results were published in cancer clinical journals. Dr. Hu implemented new statistical methodologies in biomarker evaluation with longitudinal and survival outcomes. Collaborating with his colleagues, Dr. Hu developed new statistical methods in time-to-event models with time-varying covariates. As an investigator at the statistical coordinating center for Cardiovascular Health Studies from 2006 to 2008, he managed the heart MRI and clinical data of a large follow-up observational study with 6914 participants. Dr. Hu has participated in 20 NIH funded project with a total amount of support over $25,000,000.
Survival analysis, longitudinal data analysis, meta-analysis, analysis of missing data, statistical methods in medical diagnosis and prognosis, medical research on cardiovascular disease, kidney disease, neurological disorders, and radiology.